A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung cancer

A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung cancer - A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016489

Enrollment

Registered

2015-02-09

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small-cell lung cancer

Interventions

FLT-PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Good general condition 2)Patient with non small cell lung cancer of adaptation of SRT 3)The patient who plans SRT and follow-up in FBRI 4)Patiant who is performed FDG-EPT/CT before treatment, or planned FDG-EPT/CT in a few days in FBRI 5)Patiant who can understand study contents, and obtain written consent

Exclusion criteria

Exclusion criteria: 1)Patient who cannot keep supine position for 30 minutes 2) Patient who is pregnant or the possibility of pregnancy 3) Patient who is severe claustrophobia 4) Patient who is regarded as unsuitable by responsible investigators

Design outcomes

Primary

Measure	Time frame
Effect of SRT on non-small-cell lung cancer	—

Countries

Japan

Contacts

Public ContactAkihito Ohnishi

Institute of Biomedical Research and Innovation Division of Molecular Imaging

ohnishi@fbri.org078-304-5212

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026